Yasuyoshi Sato

12PUBLICATIONS
37CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Radiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Aug 07, 2026
Capmatinib for High-Level MET-Amplified Metastatic Gastric Cancer Identified by Comprehensive Genomic Profiling: A Case Report and Literature Review.

|Apr 27, 2026
Site-Specific Genomic Markers Associated with Outcomes of PD-1 Blockade in Gastric and Esophagogastric Junction Cancer: Analysis of Japan's C-CAT Registry.

|Mar 31, 2025
Clinical outcomes of recurrent or metastatic head and neck cancer after failure of platinum and nivolumab: a multicenter retrospective study.

Takane Watanabe, Hiroki Oka, Kengo Nagashima

|Jul 10, 2024
Response to chemotherapy could predict the prognosis of esophageal squamous cell carcinoma treated with neoadjuvant docetaxel, cisplatin, and fluorouracil (DCF) followed by surgery: long-term results in a single institute.

Yasuyoshi Sato, Kazuhiko Mori, Shinichiro Atsumi

|Jan 31, 2024
Clinical impact of proteinuria on renal function and treatment outcomes in patients with radioiodine-refractory thyroid cancer treated with lenvatinib.

Naoki Fukuda, Kazuhisa Toda, Hirotaka Suto

|Dec 09, 2023
Alterations in Intratumoral Immune Response before and during Early-On Nivolumab Treatment for Unresectable Advanced or Recurrent Gastric Cancer.

Yasuyoshi Sato, Hiroharu Yamashita, Yukari Kobayashi

Pageof 2

Frequent Collaborators

4 joint publications

Naoki Fukuda

3 joint publications

Xiaofei Wang

3 joint publications

Junichi Tomomatsu

3 joint publications

Kenji Nakano